News and ViewsRecent Price Movement and Market Context
Torrent Pharmaceuticals’ stock has underperformed both its sector and the broader market in the short term. Over the past week, the stock has declined by 7.10%, significantly worse than the Sensex’s 2.60% drop. The one-month performance is similarly weak, with the stock down 8.68%, roughly in line with the Sensex’s 8.62% fall. However, the year-to-date figures reveal a more positive picture, with Torrent’s shares rising 3.90% compared to the Sensex’s 13.96% decline. This divergence suggests that while the stock has been hit hard recently, it remains resilient over longer periods.
On 02-Apr, the stock touched an intraday low of ₹3,871.25, down 5.78%, with a weighted average price indicating that more volume was traded near this l...
Read full news article
